News & Events
Q&A with LightOx
Headquartered in The Biosphere, LightOx develops drugs and treatments for early-stage oral cancers, wound care
Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
Study is designed to evaluate the safety and tolerability of increasing dose levels of the
NEWCASTLE ANNOUNCES LIFE SCIENCE INVESTOR OPPORTUNITY TO GROW SECTOR AND CREATE JOBS
Newcastle City Council is looking for an investor to accelerate the growth of the region's
North East Innovation Lab achieves UKAS accreditation in recognition of its high standards
The North East Innovation Lab, part of Newcastle Hospitals has achieved a major milestone with
Atelerix Limited – Strategic partnership for market expansion
Atelerix Limited, which develops and markets innovative solutions for the storage and transport of cells,
CellRev appoint former Quorn Foods and ICI Executive to the board.
Technology disrupter CellRev have appointed Ralph Pickles, former executive at ICI, CEO of Quorn Foods,
Funded and Supported by
The Biosphere is part funded by the England European Regional Development fund as part of the European Structural And Investment Funds Growth Programme 2014-2020 and the North East Local Growth Fund from HM Government, Administered by the North East Local Enterprise Partnership.